A study published in the Journal of Clinical Endicronology & Metabolism shows a drug approved to treat Crohn’s disease and ulcerative colitis leads to “rapid improvements” in bone density and structure.
A study at The Children’s Hospital of Philadelphia aims to establish reference data for children ages 1 to 5 using dual-energy X-ray absorptiometry (DXA), a test that measures bone density.
